Esperion Therapeutics
ESPR
#6459
Rank
S$1.03 B
Marketcap
S$4.01
Share price
0.32%
Change (1 day)
259.70%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Market cap: S$1.03 Billion

As of May 2026 Esperion Therapeutics has a market cap of S$1.03 Billion. This makes Esperion Therapeutics the world's 6459th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026S$1.03 B-16.13%
2025S$1.22 B101.37%
2024S$0.61 B35.98%
2023S$0.44 B-27.03%
2022S$0.61 B49.49%
2021S$0.41 B-53.82%
2020S$0.89 B-59.68%
2019S$2.21 B31.14%
2018S$1.68 B-26.93%
2017S$2.30 B464.5%
2016S$0.40 B-42.36%
2015S$0.70 B-34.78%
2014S$1.08 B307.05%
2013S$0.26 B

End of Day market cap according to different sources

On May 18th, 2026 the market cap of Esperion Therapeutics was reported to be:

S$1.03 Billion
by Nasdaq info icon info icon
S$1.03 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
S$184.77 B 17,816.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$84.49 B 8,092.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
S$3.04 B 195.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
S$1.21 B 17.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$5.82 B 464.67%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$12.28 B 1,091.47%๐Ÿ‡บ๐Ÿ‡ธ USA